FOLH1 and Familial prostate cancer: With the emergence of new prostate cancer imaging modalities, such as magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT) with choline or prostate-specific membrane antigen (PSMA), local-only recurrences are diagnosed in up to 33% of those patients [5].